HealthMuscular Dystrophy Drug Price Jumps From $1,200 To $89,000 After FDA Approval FDA approved an old muscular dystrophy drug sold overseas at $1,200 per year. The drug deflazacort will be sold in the U.S. for $89,000.by Allan Adamson
HealthStartup NeuroQore Uses Magnetic Pulses To Treat Depression: Cure Depression Without Drugs Or Psychotherapy?by Athena Chan
HealthCorticosteroid Emflaza Receives FDA Approval As Duchenne Muscular Dystrophy Treatmentby Dianne Depra
HealthKaleo Pharmaceuticals Questioned Over 550 Percent Price Hike Of Naloxone Injector Evzio For Opioid Overdoseby Allan Adamson
HealthDoctors Pull Live Cockroach From Woman’s Skull After She Complains Of ‘Crawling Sensation’by Katrina Pascual
HealthVasalgel Monkey Trial Offers Hope For Long-Acting And Reversible Male Contraceptiveby Allan Adamson
HealthCancer Drug Promotes Heart Tissue Regeneration, Could Double As Heart Disease Treatmentby Dianne Depra
HealthResearchers Turn To Artificial Intelligence To Reach New, Previously Unachievable Cancer Outcomesby Livia Rusu
Donald Trump Kisses Elon Musk's Feet in Viral AI-Generated Video Blasted on Government TV Screens Following Hack